Delcath Systems, Inc. (OTCMKTS:DCTH)’s share price fell 16.2% during mid-day trading on Monday . The company traded as low as $0.09 and last traded at $0.09, 6,753 shares were traded during mid-day trading. A decline of 90% from the average session volume of 67,863 shares. The stock had previously closed at $0.11.
The stock’s fifty day simple moving average is $0.11 and its 200-day simple moving average is $0.13.
Delcath Systems (OTCMKTS:DCTH) last issued its earnings results on Thursday, August 8th. The company reported ($0.08) earnings per share (EPS) for the quarter. The business had revenue of $0.41 million for the quarter.
About Delcath Systems (OTCMKTS:DCTH)
Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company is developing melphalan hydrochloride for Injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. It offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe.
Featured Story: Backdoor Roth IRA Conversion and Strategy
Receive News & Ratings for Delcath Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems and related companies with MarketBeat.com's FREE daily email newsletter.